Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · 2C-I

2C-I in Turkey: not individually verified

Not individually verified

We have not confirmed that 2C-I specifically is scheduled in Turkey, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. 2C-I is not confirmed as a controlled substance in Turkey and this row is a deferral rather than a finding. The dossier searched the Turkish terms «2C-I» and «4-iyodo-2,5-dimetoksifenetilamin» and the transliterations 2C-I and 4-iyodo-2,5-dimetoksifenetilamin against the classification decisions made under article 19 of Law No. 2313 on the Control of Narcotic Substances, and confirmed no current entry. It rejected the near match «2C-B», because the iodine and bromine homologues are distinct. This row is also the parent structure of 25I-NBOMe, which was itself searched separately and returned no confirmed entry, and the dossier rejected reading the two together because the NBOMe derivative is a distinct molecule. Two unconfirmed rows do not add up to a confirmed one in either direction. The annexes to the decisions footnoted to article 19 are not in the consolidated statute, so the placement cannot be stated either way from what was read.

Confirm directly with Turkey’s national drug authority or your own embassy before you rely on anything.

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.